Tracy, T.M.

Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30

Glueck, C. J., Fontaine, R. N., Wang, P., Subbiah, M. T. R., Weber, K., Illig, E., Streicher, P., Sieve-Smith, L., Tracy, T. M., Lang, J. E., et al. (2001) · Metabolism

Pharmacology and Obesity TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 188

Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2

Breslow, J. L., Zannis, V. I., SanGiacomo, T. R., Third, J. L., Tracy, T., & Glueck, C. J. (1982) · Journal of Lipid Research

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 174

Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy

Glueck, C. J., Dharashivkar, S., Wang, P., Zhu, B., Gartside, P. S., Tracy, T., & Sieve, L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 99